Screening compound: InChI=1S/C28H25ClN2O4S/c29-22-7-3-1-5-20(22)18-31-23-17-19(26(32)30-13-11-28(12-14-30)34-15-16-35-28)9-10-25(23)36-24-8-4-2-6-21(24)27(31)33/h1-10,17H,11-16,18H2

Screening compound: InChI=1S/C28H25ClN2O4S/c29-22-7-3-1-5-20(22)18-31-23-17-19(26(32)30-13-11-28(12-14-30)34-15-16-35-28)9-10-25(23)36-24-8-4-2-6-21(24)27(31)33/h1-10,17H,11-16,18H2
Screening compound: InChI=1S/C28H25ClN2O4S/c29-22-7-3-1-5-20(22)18-31-23-17-19(26(32)30-13-11-28(12-14-30)34-15-16-35-28)9-10-25(23)36-24-8-4-2-6-21(24)27(31)33/h1-10,17H,11-16,18H2 alternative view

Chemical Structure Depiction of ChemDiv screening compound
InChI=1S/C28H25ClN2O4S/c29-22-7-3-1-5-20(22)18-31-23-17-19(26(32)30-13-11-28(12-14-30)34-15-16-35-28)9-10-25(23)36-24-8-4-2-6-21(24)27(31)33/h1-10,17H,11-16,18H2

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

K788-1477

Molecular Formula

C28H25ClN2O4S (C28 H25 ClN2 O4 S)

Compound Name

10-(2-chlorobenzyl)-8-(1,4-dioxa-8-azaspiro[4.5]dec-8-ylcarbonyl)dibenzo[b,f][1,4]thiazepin-11(10H)-one

IUPAC name

9-[(2-chlorophenyl)methyl]-6-{14-dioxa-8-azaspiro[4.5]decane-8-carbonyl}-2-thia-9-azatricyclo[9.4.0.0^{38}]pentadeca-1(11)3571214-hexaen-10-one

SMILES

O=C(c(cc1)cc(N2Cc(cccc3)c3Cl)c1Sc(cccc1)c1C2=O)N(CC1)CCC11OCCO1

MDL Number (MFCD)

InChI=1S/C28H25ClN2O4S/c29-22-7-3-1-5-20(22)18-31-23-17-19(26(32)30-13-11-28(12-14-30)34-15-16-35-28)9-10-25(23)36-24-8-4-2-6-21(24)27(31)33/h1-10,17H,11-16,18H2 in Drug Discovery

Included in Screening Libraries

Eccentric PPI Library (11937 compounds)

Protein-Protein Interaction Library (218420 compounds)

Serine Proteases Inhibitors Library (32732 compounds)

Adenosine Receptors Targeted Library (19896 compounds)

Included in 1.7M Stock Database

Mechanism of action:
  • PPI modulators
  • PPI modulators
  • Receptor's ligands
Structure:
  • Cyclic compounds
Therapeutical areas:
  • Infections
  • Cancer
  • Musculoskeletal
  • Digestive system
  • Respiratory tract
  • Male
  • Female
  • Cardiovascular
  • Skin
  • Metabolic
  • Immune system
  • Cancer
  • Digestive system
  • Respiratory tract
  • Nervous system
  • Eye
  • Cardiovascular
Targets:
  • Proteases
  • GPCR

References: we are preparing a list of scientific research reports with InChI=1S/C28H25ClN2O4S/c29-22-7-3-1-5-20(22)18-31-23-17-19(26(32)30-13-11-28(12-14-30)34-15-16-35-28)9-10-25(23)36-24-8-4-2-6-21(24)27(31)33/h1-10,17H,11-16,18H2 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound InChI=1S/C28H25ClN2O4S/c29-22-7-3-1-5-20(22)18-31-23-17-19(26(32)30-13-11-28(12-14-30)34-15-16-35-28)9-10-25(23)36-24-8-4-2-6-21(24)27(31)33/h1-10,17H,11-16,18H2?
Check Price and Availability of InChI=1S/C28H25ClN2O4S/c29-22-7-3-1-5-20(22)18-31-23-17-19(26(32)30-13-11-28(12-14-30)34-15-16-35-28)9-10-25(23)36-24-8-4-2-6-21(24)27(31)33/h1-10,17H,11-16,18H2, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of InChI=1S/C28H25ClN2O4S/c29-22-7-3-1-5-20(22)18-31-23-17-19(26(32)30-13-11-28(12-14-30)34-15-16-35-28)9-10-25(23)36-24-8-4-2-6-21(24)27(31)33/h1-10,17H,11-16,18H2 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for InChI=1S/C28H25ClN2O4S/c29-22-7-3-1-5-20(22)18-31-23-17-19(26(32)30-13-11-28(12-14-30)34-15-16-35-28)9-10-25(23)36-24-8-4-2-6-21(24)27(31)33/h1-10,17H,11-16,18H2
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for InChI=1S/C28H25ClN2O4S/c29-22-7-3-1-5-20(22)18-31-23-17-19(26(32)30-13-11-28(12-14-30)34-15-16-35-28)9-10-25(23)36-24-8-4-2-6-21(24)27(31)33/h1-10,17H,11-16,18H2
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of InChI=1S/C28H25ClN2O4S/c29-22-7-3-1-5-20(22)18-31-23-17-19(26(32)30-13-11-28(12-14-30)34-15-16-35-28)9-10-25(23)36-24-8-4-2-6-21(24)27(31)33/h1-10,17H,11-16,18H2 available by request